271 results on '"DOBRZYCKI, SLAWOMIR"'
Search Results
2. Noise and light exposure and cardiovascular outcomes: A review of evidence, potential mechanisms and implications
3. The outcome of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) and impaired kidney function: a 3-year observational study
4. Effect of Sex on Outcomes of Coronary Rotational Atherectomy Percutaneous Coronary Intervention (From the European Multicenter Euro4C Registry)
5. Short and mid-term impact of ozone on myocardial infarction incidence in Poland
6. Hepcidin – Potential biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions
7. Perioperative thrombocytopenia predicts poor outcome in patients undergoing transcatheter aortic valve implantation
8. Thrombocytopenia associated with TAVI—The summary of possible causes
9. Clinical Outcomes of Left Main Coronary Artery PCI With Rotational Atherectomy
10. Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial
11. Renalase, kidney and cardiovascular disease: Are they related or just coincidentally associated?
12. Pericarditis and Takotsubo Syndrome—Diagnosis of Cardiac Complications of Post-Acute COVID-19 Syndrome in a 77-Year-Old Woman
13. TCT-188 Safety and Efficacy of Intravascular Lithotripsy in the Management of Stent Underexpansion Among Elderly Patients
14. Echocardiography, Computed Tomography and Magnetic Resonance Imaging in the Differential Diagnosis of a Tumor in the Left Atrium of the Heart
15. Impact of diabetes on mortality and complications after coronary artery by-pass graft operation in patients with left main coronary artery disease
16. Natural history and risk factors of long-term mortality in acute coronary syndrome patients with cardiogenic shock
17. Biomarkers of Contrast-Induced Nephropathy: Which Ones and What Is Their Clinical Relevance?
18. Circulating miR-30a-5p as a prognostic biomarker of left ventricular dysfunction after acute myocardial infarction
19. Does Lack of ST-Segment Resolution Still Have Prognostic Value 6 Years After an Acute Myocardial Infarction Treated With Coronary Intervention?
20. GRACE, TIMI, Zwolle and CADILLAC risk scores — Do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?
21. Fractional Flow Reserve in the Diagnosis of Ischemic Heart Disease in a Patient with Coronary Artery Ectasia
22. TCT-101 Long-Term Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected Left Main Coronary Artery: Multicenter LM-DRAGON Registry
23. Gut Microbiome in Chronic Coronary Syndrome Patients
24. Do CHA2DS2VASc and HAS-BLED scores influence ‘real-world’ anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre
25. The value of apelin-36 and brain natriuretic peptide measurements in patients with first ST-elevation myocardial infarction
26. Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
27. Does climate change affect the chronobiological trends in the occurrence of acute coronary syndrome?
28. Myocardial perfusion assessed by contrast echocardiography correlates with angiographic perfusion parameters in patients with a first acute myocardial infarction successfully treated with angioplasty
29. Ocular haemodynamics in patients with type 2 diabetes and coronary artery disease
30. 6‐year results of BiOSS stents in coronary bifurcation treatment
31. Transcatheter transseptal mitral valve implantation with Edwards SAPIEN 3: the first experience of a single center
32. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score
33. Safety and Feasibility of a Novel Dosing Regimen of Tirofiban Administered in Patients with Acute Myocardial Infarction with ST Elevation Before Primary Coronary Angioplasty: A Pilot Study
34. The effect of serum uric acid levels on the long-term prognosis of patients with non-ST-elevation myocardial infarction
35. Serum miRNA Profile in Diabetic Patients with Ischemic Heart Disease as a Promising non-invasive Biomarker
36. Clinical outcomes of PCI with rotational atherectomy: the European multicentre Euro4C registry
37. The GRACE Scale in the Prognosis of Patients with Takotsubo Syndrome
38. Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials
39. Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies
40. Circadian variations of interleukin 6 in coronary circulations of patients with myocardial infarction
41. Coronary blood flow in patients with end-stage renal disease assessed by thrombolysis in myocardial infarction frame count method
42. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?
43. Percutaneous coronary interventions affect concentrations of interleukin 6 and its soluble receptors in coronary sinus blood in patients with stable angina
44. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease
45. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals
46. Value of the real-time myocardial contrast echocardiography for risk stratification and for the detection of significant coronary stenosis in patients with end-stage renal disease
47. Neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine and eGFR in patients with normal serum creatinine undergoing coronary angiography
48. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention
49. Estimation of glomerular filtration rate in patients with normal serum creatinine undergoing primary PCI: is it really normal?
50. Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history*
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.